Vials of a Covid-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China. Reuters/File
• Cansino Bio only company to have conducted clinical trials in Pakistan
• Around 20m doses to be available in next six months
• Another Chinese firm to conduct clinical trial
ISLAMABAD: The Drug Regulatory Authority of Pakistan (Drap) on Friday issued emergency use authorisation to the Chinese company Cansino Biologics Inc’s Covid-19 vaccine after which supply of the doses will start in a few weeks.
Pak Approves Fourth COVID-19 Vaccine
FOLLOW US ON:
Islamabad: Pakistan has approved the emergency use of a second Chinese COVID-19 vaccine, making it the fourth drug to be cleared by the regulatory authority to tackle the deadly virus, which has claimed over 12,000 lives in the country. Chinese company Cansino Biologics Inc s vaccine was approved by the Drug Regulatory Authority of Pakistan (Drap) on Friday. Drap officials said that after its approval for emergency use, the supply of the doses will start in a few weeks. Cansino Bio is the only vaccine for which Pakistan conducted a clinical trial, with around 18,000 volunteers participating from across the country.
Ag APPISLAMABAD: The Drug Regulatory Authority of Pakistan on Friday approved a second Chinese-developed coronavirus vaccine from CanSino Biologics for emergency use, Geo News.